GE HealthCare agrees to acquire SOFIE Biosciences in $945m deal
The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027.
Accelerate decision-making with data-led confidence
Combine proprietary data, human expertise, and purpose-built AI to uncover insights and accelerate better business decisions.
Discover our solutions
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme
Intuitive Surgical expands platforms despite market headwind